Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
Market Place
ABOUT THIS PAGE
A Levomepromazine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Levomepromazine Hydrochloride, including repackagers and relabelers. The FDA regulates Levomepromazine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Levomepromazine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Levomepromazine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Levomepromazine Hydrochloride supplier is an individual or a company that provides Levomepromazine Hydrochloride active pharmaceutical ingredient (API) or Levomepromazine Hydrochloride finished formulations upon request. The Levomepromazine Hydrochloride suppliers may include Levomepromazine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Levomepromazine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Levomepromazine Hydrochloride Drug Master File in Japan (Levomepromazine Hydrochloride JDMF) empowers Levomepromazine Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Levomepromazine Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Levomepromazine Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Levomepromazine Hydrochloride suppliers with JDMF on PharmaCompass.
Levomepromazine Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Levomepromazine Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Levomepromazine Hydrochloride GMP manufacturer or Levomepromazine Hydrochloride GMP API supplier for your needs.
A Levomepromazine Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Levomepromazine Hydrochloride's compliance with Levomepromazine Hydrochloride specifications and serves as a tool for batch-level quality control.
Levomepromazine Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Levomepromazine Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Levomepromazine Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Levomepromazine Hydrochloride EP), Levomepromazine Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Levomepromazine Hydrochloride USP).
LOOKING FOR A SUPPLIER?
